Literature DB >> 1519669

Localization of transforming growth factor-alpha in human appendageal tumors.

E Finzi1, T Ho, G Anhalt, W Hawkins, R Harkins, T Horn.   

Abstract

Transforming growth factor-alpha (TGF alpha) is a potent mitogen for epithelial cells that has been localized to normal human appendageal epithelia. To further understand the role of TGF alpha in human appendages, we examined TGF alpha expression immunohistochemically in 17 types of human appendageal tumors differentiating toward hair follicles, eccrine, apocrine, and sebaceous glands. In order of decreasing degrees of differentiation, tumors could be divided into hyperplasias, adenomas, benign epitheliomas, and primordial epitheliomas. Using an antibody that recognizes primarily the 6-kd and 13-kd forms of TGF alpha, TGF alpha immunostaining in 16 of 17 tumor types analyzed was found to follow a similar pattern, with expression in hyperplasias greater than adenomas greater than benign epitheliomas greater than primordial epitheliomas. Within a given tumor, TGF alpha expression also correlated well with the known differentiation state of the tumor cell types. The results suggest that TGF alpha expression is directly correlated with the differentiation state of hair follicle, eccrine, apocrine, and sebaceous tumors in human skin, and raises the possibility that TGF alpha may play a role in the differentiation of appendageal epithelia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519669      PMCID: PMC1886708     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Multiple malignant Spiegler tumors with brachydactyly and racket-nails. Light and electron microscopic study.

Authors:  D Tsambaos; A Greither; C E Orfanos
Journal:  J Cutan Pathol       Date:  1979-02       Impact factor: 1.587

2.  Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast.

Authors:  E P Sandgren; N C Luetteke; R D Palmiter; R L Brinster; D C Lee
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  Syringocystadenoma papilliferum. An electron microscopic study.

Authors:  K Hashimoto
Journal:  Arch Dermatol Forsch       Date:  1972

4.  Eruptive hidradenoma and syringoma. Histological, histochemical, and electron microscopic studies.

Authors:  K Hashimoto; R J DiBella; G M Borsuk; W F Lever
Journal:  Arch Dermatol       Date:  1967-11

5.  The dermal duct tumor.

Authors:  R K Winkelmann; W A McLeod
Journal:  Arch Dermatol       Date:  1966-07

6.  TGF-alpha is widely expressed in differentiated as well as hyperproliferative skin epithelium.

Authors:  E Finzi; R Harkins; T Horn
Journal:  J Invest Dermatol       Date:  1991-03       Impact factor: 8.551

7.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

8.  Pilar sheath acanthoma. A new benign follicular tumor.

Authors:  J Bhawan
Journal:  J Cutan Pathol       Date:  1979-10       Impact factor: 1.587

9.  Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.

Authors:  G J Todaro; J E De Larco; S Cohen
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

10.  Syringocystadenoma papilliferum: light and electron microscopic studies.

Authors:  K Niizuma
Journal:  Acta Derm Venereol       Date:  1976       Impact factor: 4.437

View more
  3 in total

Review 1.  Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia.

Authors:  J A Schroeder; D C Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Prognostic relevance of transforming growth factor alpha (TGF-alpha) and tumor necrosis factor alpha (TNF-alpha) detected in breast cancer tissues by immunohistochemistry.

Authors:  Z Bebök; B Márkus; P Németh
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.

Authors:  Laure Rittié; Sanjay Kansra; Stefan W Stoll; Yong Li; Johann E Gudjonsson; Yuan Shao; Lowell E Michael; Gary J Fisher; Timothy M Johnson; James T Elder
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.